SPARTANBURG, S.C. (May 20, 2020)—While nearly every state has a prescription drug monitoring program (PDMP), not all of the data collected crosses state lines to other pharmacies and health care providers. A new partnership between QS/1 and Scriptera will push PDMP information in real time to stakeholders who need to see it.
“While PDMPs do an incredible job collecting data, there is no guarantee that information is shared with other states,” said Ed Vess, QS/1 director of pharmacy professional affairs. “Scriptera works to share critical prescribing and dispensing data that is missing.”
Community pharmacies can subscribe to the service and see prescribing habits, as well as the percentage of controlled versus non-controlled substances dispensed by prescribers. Pharmacies can also be notified through Scriptera when a prescriber has over-prescribed dangerous medications. When implemented with one of QS/1’s pharmacy management solutions, like NRx, RxCare Plus, or SharpRx, it is a game changer for protecting patients.
"Scriptera is excited to be partnering with QS/1 to roll out our proprietary software solution,” said Kevin Laxer, founder of Scriptera. “QS1 is truly a technology-focused company, offering their clients first-class service. Scriptera's software is designed to enhance a pharmacy’s collaboration with entities inside the pharmaceutical chain to identify and solve complex issues, specifically dealing with the opioid crisis and prescription drug abuse.”
Scriptera's set of tools facilitates data-driven decisions and helps to reduce the amount of time pharmacists spend on these issues. Participation in the Scriptera solution reflects QS/1’s ongoing commitment to help eradicate the opioid epidemic.
Visit qs1.com for more information.
